159 related articles for article (PubMed ID: 8996411)
1. "Glitazones", a prospect for non-insulin-dependent diabetes.
Petrie J; Small M; Connell J
Lancet; 1997 Jan; 349(9045):70-1. PubMed ID: 8996411
[No Abstract] [Full Text] [Related]
2. New directions in treating insulin resistance.
Reusch JE
Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840
[No Abstract] [Full Text] [Related]
3. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
4. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
Westerbacka J; Yki-Järvinen H
Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
[No Abstract] [Full Text] [Related]
5. [Thiazolidinediones].
Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
[No Abstract] [Full Text] [Related]
6. New diabetes drug targets insulin resistance.
Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
[No Abstract] [Full Text] [Related]
7. Troglitazone for non-insulin-dependent diabetes mellitus.
Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
[No Abstract] [Full Text] [Related]
8. Learning to use troglitazone.
Riddle MC
Diabetes Care; 1998 Sep; 21(9):1389-90. PubMed ID: 9727881
[No Abstract] [Full Text] [Related]
9. Efficacy of troglitazone measured by insulin resistance index.
Nagasaka S; Iwamoto Y; Ishikawa S; Kuzuya T; Saito T
Lancet; 1997 Jul; 350(9072):184. PubMed ID: 9250189
[No Abstract] [Full Text] [Related]
10. Glitazones and NIDDM.
Sakane N; Yoshida T; Kondo M
Lancet; 1997 Mar; 349(9056):952. PubMed ID: 9093269
[No Abstract] [Full Text] [Related]
11. Troglitazone and small low-density lipoprotein in type 2 diabetes.
Hirano T; Yoshino G; Kazumi T
Ann Intern Med; 1998 Jul; 129(2):162-3. PubMed ID: 9669982
[No Abstract] [Full Text] [Related]
12. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Kitaoka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
[No Abstract] [Full Text] [Related]
13. [Insulin sensitizer. A new therapy option for type 2 diabetic patients].
Filz HP
MMW Fortschr Med; 2000 Sep; 142(38):31-3. PubMed ID: 11050888
[TBL] [Abstract][Full Text] [Related]
14. The glitazones: proceed with caution.
Krische D
West J Med; 2000 Jul; 173(1):54-7. PubMed ID: 10903299
[No Abstract] [Full Text] [Related]
15. New treatment for adult-onset diabetes.
Zurlinden J
Nurs Spectr (Wash D C); 1997 Aug; 7(16):8. PubMed ID: 9439332
[No Abstract] [Full Text] [Related]
16. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
Algenstaedt P; Hamann A
Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
[No Abstract] [Full Text] [Related]
17. Troglitazone.
Santiago JV
Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
[No Abstract] [Full Text] [Related]
18. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.
Mudaliar S; Henry RR
Annu Rev Med; 2001; 52():239-57. PubMed ID: 11160777
[TBL] [Abstract][Full Text] [Related]
19. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus.
Minamikawa J; Yamauchi M; Inoue D; Koshiyama H
J Clin Endocrinol Metab; 1998 Mar; 83(3):1041-2. PubMed ID: 9506772
[No Abstract] [Full Text] [Related]
20. Cardiovascular effects of troglitazone.
Umland EM; Romanelli AM
Ann Pharmacother; 1999 Feb; 33(2):229-32. PubMed ID: 10084419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
